Assessing the Impact of Insulin Glargine and Detemir Treatment to Serum Total IGF1 Levels in the Insulin-Naive Type 2 Diabetic Patients
METABOLIC SYNDROME AND RELATED DISORDERS, vol.15, no.5, pp.220-225, 2017 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 15 Issue: 5
- Publication Date: 2017
- Doi Number: 10.1089/met.2017.0005
- Journal Name: METABOLIC SYNDROME AND RELATED DISORDERS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.220-225
- Bursa Uludag University Affiliated: Yes
Abstract
Aim: The mitogenic potential of analog insulins due to their different insulin-like growth factor-1 (IGF1) receptor affinity is a situation that causes concern related to cancer risk. We aimed to examine the changes in the serum IGF1 levels formed by insulin glargine and detemir in the insulin-naive type 2 diabetic patients.